Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
186.60
+5.04 (2.78%)
Jun 23, 2026, 4:00 PM EDT - Market closed
CRL Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 25, 2021 |
| 4,027 | 4,015 | 4,050 | 4,129 | 3,976 | 3,540 | |
Revenue Growth (YoY) | 0.11% | -0.85% | -1.92% | 3.86% | 12.31% | 21.07% |
Cost of Revenue | 2,727 | 2,692 | 2,718 | 2,627 | 2,513 | 2,206 |
Gross Profit | 1,300 | 1,323 | 1,332 | 1,503 | 1,463 | 1,335 |
Selling, General & Admin | 724.7 | 743.07 | 751 | 747.86 | 665.1 | 619.92 |
Depreciation & Amortization Expenses | 129.15 | 179.07 | 138.47 | 137.44 | 146.58 | 124.86 |
Other Operating Expenses | - | 375.97 | 215 | - | - | - |
Total Operating Expenses | 853.84 | 1,298 | 1,104 | 885.3 | 811.68 | 744.78 |
Operating Income | 70.39 | 25.16 | 227.35 | 617.26 | 650.98 | 589.86 |
Interest Income | 4.57 | 4.94 | 8.58 | 5.2 | 0.78 | 0.65 |
Interest Expense | -105.89 | -107.03 | -126.29 | -136.71 | -59.29 | -73.91 |
Other Non-Operating Income (Expense) | -134.5 | -22.58 | -16.52 | 95.54 | 30.52 | -35.89 |
Total Non-Operating Income (Expense) | -235.81 | -124.67 | -134.23 | -35.98 | -27.99 | -109.15 |
Pretax Income | -165.42 | -99.5 | 93.11 | 581.28 | 622.99 | 480.71 |
Provision for Income Taxes | 17.42 | 42.66 | 67.82 | 100.91 | 130.38 | 81.87 |
Net Income | -182.84 | -142.16 | 25.29 | 480.37 | 492.61 | 398.84 |
Minority Interest in Earnings | 1.81 | 2.18 | 14.99 | 5.75 | 6.38 | 7.86 |
Net Income to Common | -169.81 | -144.34 | 22.2 | 474.62 | 486.23 | 390.98 |
Net Income Growth | - | - | -95.32% | -2.39% | 24.36% | 7.32% |
Shares Outstanding (Basic) | 48 | 50 | 51 | 51 | 51 | 50 |
Shares Outstanding (Diluted) | 48 | 50 | 51 | 51 | 51 | 51 |
Shares Change (YoY) | -1.93% | -3.44% | 0.38% | -0.21% | -0.24% | 1.61% |
EPS (Basic) | -3.53 | -2.91 | 0.43 | 9.27 | 9.57 | 7.77 |
EPS (Diluted) | -3.53 | -2.91 | 0.43 | 9.27 | 9.48 | 7.60 |
EPS Growth | - | - | -95.34% | -2.21% | 24.74% | 5.56% |
Free Cash Flow | 391.29 | 518.49 | 501.61 | 365.37 | 294.91 | 532.03 |
Free Cash Flow Growth | -24.53% | 3.37% | 37.29% | 23.89% | -44.57% | 40.00% |
Free Cash Flow Per Share | 8.12 | 10.45 | 9.76 | 7.14 | 5.75 | 10.35 |
Gross Margin | 32.29% | 32.96% | 32.88% | 36.39% | 36.79% | 37.70% |
Operating Margin | 1.75% | 0.63% | 5.61% | 14.95% | 16.37% | 16.66% |
Profit Margin | -4.54% | -3.54% | 0.62% | 11.63% | 12.39% | 11.27% |
FCF Margin | 9.72% | 12.91% | 12.39% | 8.85% | 7.42% | 15.03% |
EBITDA | 420.49 | 428.47 | 589.09 | 931.39 | 954.85 | 855.4 |
EBITDA Margin | 10.44% | 10.67% | 14.55% | 22.55% | 24.01% | 24.16% |
EBIT | 70.39 | 25.16 | 227.35 | 617.26 | 650.98 | 589.86 |
EBIT Margin | 1.75% | 0.63% | 5.61% | 14.95% | 16.37% | 16.66% |
Effective Tax Rate | -10.53% | -42.87% | 72.84% | 17.36% | 20.93% | 17.03% |